Results 91 to 100 of about 17,859 (212)
Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events [PDF]
, 2009 Epidemiological evidence has suggested a link between beta(2)-agonists and increased asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta(2)-agonists are safe ...Altman, Anonymous, Arthurs, Aubier, Bailey, Barnes, Bateman, Bateman, Bateman, Bateman, Bateman, Bateman, Bateman, Beach, Bons, Boushey, Boushey, Boushey, Bousquet, Bousquet, Bousquet, Briggs, Busse, Busse, Castle, Cates, Cates, Cates Christopher, Clark, Clark, Clark, Clark, Clark, Cordier, Ducharme, Edin, Giembycz, Godard, Greenstone, Ind, Jarjour, Juniper, Kavuru, Koenig, Koopmans, Lipworth, Lundbäck, Malone, Murray, Nathan, Nathan, Nelson, Nelson, Ni Chroinin, Ni Chroinin, Noord, Pauwels, Pauwels, Pauwels, Pearce, Pearlman, Pearlman, Pedersen, Pedersen, Pederson, Rojas, Rooklin, Salpeter, Sears, Shapiro, Strand, Wallin, Walters, Walters, Weinstein +74 morecore +1 more sourceLow-dose Fluticasone Propionate in Combination With Salmeterol in Patients With Chronic Obstructive Pulmonary Disease
Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 2018 Inhaled corticosteroids are widely used in the treatment of chronic obstructive pulmonary disease (COPD). However, their use has been questioned for appropriate dose and a possible increased risk of pneumonia. Here, we reviewed patients with COPD who had Hideki Yasui, Naoki Inui, Tomoyuki Fujisawa, Masato Karayama, Noriyuki Enomoto, Yutaro Nakamura, Shigeki Kuroishi, Hisano Ohba, Koshi Yokomura, Jun Sato, Masaki Sato, Naoki Koshimizu, Mikio Toyoshima, Takashi Yamada, Masafumi Masuda, Toshihiro Shirai, Takafumi Suda +16 moredoaj +1 more sourceLong-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. [PDF]
, 2014 BACKGROUND: Pharmacological therapy for chronic obstructive pulmonary disease (COPD) is aimed at relieving symptoms, improving quality of life and preventing or treating exacerbations.Treatment tends to begin with one inhaler, and additional therapies ...Aalbers, Abrahams, Abrahams, Adams, Agusti, Allegra, Ambrosino, Amgott, Anderson, Anonymous, Anthonisen, Antoniu, Anzueto, Anzueto, Appleton, Arievich, Auffarth, Bale, Barnes, Barnes, Barnes, Barr, Bateman, Bateman, Bateman, Bateman, Bateman, Bateman, Bateman, Bateman, Bateman, Baumgartner, Beeh, Beeh, Beeh, Berger, Bleecker, Bleecker, Bleecker, Bogdan, Bogdan, Bourbeau, Bourbeau, Braido, Briggs, Briggs, Briggs, Briggs, Brightling, Brusasco, Brusasco, Buhl, Buhl, Burge, Burge, Burge, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley PMA (on behalf of the Symbicort® study group), Calverly, Calverly, Campbell, Campbell, Casaburi, Cazzola, Cazzola, Celli, Celli, Celli, Celli, Celli, Celli, Celli, Celli, Celli, Celli, Celli, Celli, Celli, Celli, Celli, Chan, Chapman, Chavannes, Chavannes, Chavannes, Chong, Choudhury, Chuck, Cipriani, Claverley, Cooper, Cooper, Cooper, Cooper, Cope, Cope, Corhay, Corhay, Covelli, Crim, Culpitt, D'Amato, D'Urzo, D'Urzo, D'Urzo, D'Urzo, D'Urzo, D'Urzo, Dahl, Dahl, Dahl, Dahl, Dahl, Dahl, Dahl, Dal Negro, Dal Negro, Dalal, Dalal, Dawber, Decramer, Decramer, Decramer, Decramer, Decramer, Decramer, Decramer, Decramer, Decramer, Decramer, Derenne, Dias, Dias, Dias, DiSantostefano, Doherty, Doherty, Doherty, Doherty, Dong, Donohue, Donohue, Donohue, Donohue, Donohue, Dransfield, Dunn, Dusser, Dusser, Dusser, Earnshaw, Eden, Edin, Effing, Eichenhorn, Fang, Fattore, Ferguson, Ferguson, Ferguson, Ferguson, Ferguson, Ferguson, Ferguson, Ferguson, Ferguson, Ferguson, Ferreira, Freeman, Freeman, Friedman, Frith, Fukuchi, Fukuchi, Geake, Gelb, Gizycki, Glaab, Greefhorst, Greefhorst, Greefhorst, Gross, Grunsven, Grunsven, Guenette, Halpin, Halpin, Halpin, Hanania, Hanania, Hanania, Hanania, Hanrahan, Hanrahan, Hanrahan, Hanrahan, Hanrahan, Hattotuwa, Hettle, Hodder, Hogan, Hoogendoorn, Horstman, Houghton, Hunjan, Hunjan, Hutchinson, Inoue, Janssens, Jarad, Jenkins, Jenkins, Johansson, John, Johnell, Johnson, Jones, Jones, Jones, Jones, Jones, Jones, Jones, Jones, Jones, Jones, Jones, Jones, Jones, Jones, Jones, Jones, Kaptein, Kardos, Kardos, Karner, Karner, Karner, Karner, Kato, Keene, Kerstjens, Kerstjens, Kerstjens, Kerstjens, Kerstjens, Kerstjens, Kerwin, Kerwin, Kerwin, Kerwin, Kerwin, Kerwin, Kesten, Kesten, Kesten, Kew, Kew, Khamis, Korenblat, Kornmann, Kornmann, Kristufek, Kristufek, Kristufek, Kunz, Lacasse, Langley, Lapperre, Laties, Littner, Llewellyn-Jones, Lofdahl, Lofdahl, Lofdahl, Lofdahl, Loke, Loppow, Lu, Lung Health Study Research Group, Löfdahl, Magnussen, Mahler, Mahler, Mahler, Mahler, Mahler, Mahler, Mahler, Mahler, Mahmud, Martinez, Matiz-Bueno, Matiz-Bueno, McDonough, McGarvey, McGarvey, McGarvey, Meer Regina, Mirici, Moen, Moita, Moita, Morice, Morice, Nannini, Nannini, Nannini, Nelson, Nelson, Nelson, Nelson, Nelson, Niewoehner, Niewoehner, Nishimura, Nitschmann, Noppen, O'Donnell, Ohar, Osztovits, Overbeek, Ozol, Ozol, Paggiaro, Paggiaro, Paggiaro, Paggiaro, Pauwels, Pauwels, Pauwels, Powrie, Powrie, Puhan, Puhan, Qiu, Qiu, Rabe, Renkema, Renkema, Rennard, Rennard, Rennard, Rennard, Rennard, Rennard, Rennard, Rennard, Rice, Rizzato, Robertson, Rodrigo, Rodrigo, Rodriguez Gonzalez-Moro, Rossi, Rutgers, Rutten-van Molken, Rutten-van Molken, Rutten-van Mölken, Rutten-van Mölken, Rutten-van Mölken, Sacchetta, Scanlon, Schermer, Sciurba, Sciurba, Scott, Scott, Seemungal, Seemungal, Senderovitz, Senderovitz, Serby, Sestini, Shaker, Shaker, Sharafkhaneh, Sharafkhaneh, Sharafkhaneh, Sin, Sin, Singh, Singh, Singh, Southard, Spencer, Spencer, Spencer, Spencer, Spencer, Spencer, Spencer, Spencer, Spiegelhalter, Stockley, Sun, Szafranski, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Thompson, Thompson, To, Tonnei, Tonnel, Troosters, Troosters, Valk, Verhoeven, Verhoeven, Verhoeven, Verhoeven, Verhoeven, Verkindre, Vestbo, Vestbo, Vestbo, Vestbo, Vestbo, Vestbo, Vestbo, Vestbo, Vestbo, Vogelmeier, Vogelmeier, Vogelmeier, Vogelmeier, Vogelmeier, Vogelmeier, Voshaar, Voshaar, Wadbo, Watkins, Wedzicha, Wedzicha, Wedzicha, Wedzicha, Wedzicha, Weel, Weiner, Weiner, Weir, Weir, Weir, Weir, Welsh, Welte, Welte, Welte, Welte, Welte, Wempe, Wouters, Yan, Yang, Yildiz, Zaniolo, Zheng, Zheng, Zhong, Zhong, Zhong, Zu Wallack, ZuWallack +511 morecore +1 more sourceReal-world research and its importance in respiratory medicine [PDF]
, 2015 Peer reviewedPublisher ...Brusselle, Guy, Chisholm, Alison, Freeman, Daryl, Price, David, Roche, Nicolas +4 morecore +6 more sourcesCost-effectiveness of combination fluticasone propionate–salmeterol 250/50 μg versus salmeterol in severe COPD patients
International Journal of COPD, 2010 Anand A Dalal1, Meaghan St Charles2, Hans V Petersen2, Melissa H Roberts2, Christopher M Blanchette2, Kathy Manavi-Zieverink31US Health Outcomes, GlaxoSmithKline, Research Triangle Park, NC, 2Division of Clinical and Outcomes Research, Lovelace ...An, A Dalal, Meaghan St Charles, Hans V Petersen, et al +4 moredoaj Relative Bioavailability of Inhaled Fluticasone Propionate and Salmeterol – is Population Pharmacokinetic Modelling a Relevant Alternative to a Non-Compartmental Approach?
Drug Design, Development and TherapyJohan Rosenborg,1 Per Bäckman,2 Thomas Bengtsson,1 Scott Haughie3 1StatMind AB, Lund, Sweden; 2Emmace Consulting AB, Lund, Sweden; 3Viatris, Mylan Pharma UK Ltd, Sandwich, UKCorrespondence: Johan Rosenborg, Email johan.rosenborg@statmind.se Per Bäckman ...Rosenborg J, Bäckman P, Bengtsson T, Haughie S +3 moredoaj Alterations in vasodilator-stimulated phosphoprotein (VASP) phosphorylation: associations with asthmatic phenotype, airway inflammation and β\u3csub\u3e2\u3c/sub\u3e-agonist use [PDF]
, 2006 Background
Vasodilator-stimulated phosphoprotein (VASP) mediates focal adhesion, actin filament binding and polymerization in a variety of cells, thereby inhibiting cell movement.Batra, Vikas, Cirelli, Rosemary, Foster, Gayle C., Hastie, Annette T., Hawkins, Gregory A., Peters, Stephen P., Rybinski, Katherine A., Wu, Min, Zangrilli, James G. +8 morecore +1 more sourceFluticasone propionate-salmeterol versus inhaled corticosteroids plus montelukast: outcomes study in pediatric patients with asthma
Journal of Asthma and Allergy, 2012 Richard H Stanford,1 Manan Shah,2 Anna O D'Souza21GlaxoSmithKline, Research Triangle Park, Durham, NC, 2Xcenda, Palm Harbor, FL, USABackground: The purpose of this study (GSK ADA111194) was to compare asthma-related health care utilization and ...Stanford RH, Shah M, D'Souza AOdoaj
